Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranjit Manchanda

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Diagnostics (Basel, Switzerland)|November 24, 2023
Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-AnalysisFaiza Gaba, Oleg Blyuss, Dhivya Chandrasekaran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2026
Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleedingAdeola Olaitan, Nora Pashayan, John Butler, et al.
International Journal of Cancer|January 29, 2026
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancerElisa Redl, Chiara Herzog, Charlotte Vavourakis, et al.
American Journal of Obstetrics and Gynecology|April 25, 2025
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysisAshwin Kalra, Subhasheenee Ganesan, Jacqueline J Y Sia, et al.
Cancers|July 26, 2020
Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health SystemsRanjit Manchanda, Li Sun, Shreeya Patel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 5, 2021
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort studySudha Sundar, Carole Cummins, Satyam Kumar, et al.
Journal of the National Cancer Institute|December 2, 2014
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialRanjit Manchanda, Kelly Loggenberg, Saskia Sanderson, et al.
JAMA Network Open|February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast CancerXia Wei, Li Sun, Eric Slade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2021
British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemicAlexandra Taylor, Sudha S Sundar, Rebecca Bowen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologistsMurat Gultekin, Polat Dursun, Boris Vranes, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Diagnostics (Basel, Switzerland)|November 24, 2023
Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-AnalysisFaiza Gaba, Oleg Blyuss, Dhivya Chandrasekaran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2026
Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleedingAdeola Olaitan, Nora Pashayan, John Butler, et al.
International Journal of Cancer|January 29, 2026
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancerElisa Redl, Chiara Herzog, Charlotte Vavourakis, et al.
American Journal of Obstetrics and Gynecology|April 25, 2025
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysisAshwin Kalra, Subhasheenee Ganesan, Jacqueline J Y Sia, et al.
Cancers|July 26, 2020
Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health SystemsRanjit Manchanda, Li Sun, Shreeya Patel, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 5, 2021
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort studySudha Sundar, Carole Cummins, Satyam Kumar, et al.
Journal of the National Cancer Institute|December 2, 2014
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialRanjit Manchanda, Kelly Loggenberg, Saskia Sanderson, et al.
JAMA Network Open|February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast CancerXia Wei, Li Sun, Eric Slade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 19, 2021
British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemicAlexandra Taylor, Sudha S Sundar, Rebecca Bowen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologistsMurat Gultekin, Polat Dursun, Boris Vranes, et al.
Pageof 14